Tag - ips

 
 

IPS

Japan Times
BUSINESS / Companies
Jun 3, 2016
Fujifilm's new chief aims to make drug operations profitable
Fujifilm Holdings Corp.'s new president, Kenji Sukeno, aims to make its pharmaceutical operations profitable and said the company will consider acquisitions to bolster growth in sectors where it has an existing presence.
JAPAN / Science & Health
Feb 19, 2016
Japanese team finds new way to create, research Parkinson's stem cells
Researchers from Juntendo and Keio universities have come up with a quicker and easier way to generate iPS cells from people with Parkinson's disease, a discovery they claim will go a long way in developing a cure for the neurological disease.
BUSINESS / Companies / FOCUS
Jun 16, 2015
Nobel laureate Yamanaka allies with Takeda in hunt for blockbuster drugs
When Christophe Weber went after his first deal as head of Takeda Pharmaceutical Co., he veered off the well-worn path to the U.S. and Europe and went to Japan's Kyoto University instead.
BUSINESS / Companies
Mar 31, 2015
Fujifilm to acquire U.S. biotech company
Fujifilm Co. said Monday it will buy a U.S.-based developer of induced pluripotent stem (iPS) cells to strengthen its position in the field of regenerative medicine field, especially new drug development.
EDITORIALS
Sep 21, 2014
iPS treatment window opens
This month's transplant of a retina sheet made of induced pluripotent stem cells into a human being marks a Japanese milestone toward the application of iPS cells in the treatment of disease.

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.